Dr Raymond Oppong

Dr Raymond Oppong

Institute of Applied Health Research
Senior Lecturer in Health Economics

Contact details

Health Economics
Institute of Applied Health Research
Occupational Health Building
University of Birmingham
B15 2TT

Dr Raymond Oppong is a Senior Lecturer at the Health Economics Unit, University of Birmingham. 

He is an enthusiastic researcher who is interested in issues such as economic evaluation in the area of musculoskeletal disease, the economics of antimicrobial resistance, quality of life research and economic analysis alongside multinational, cluster and factorial trials. 

He has published in journals such as The Lancet, British Journal of General Practice, The European Journal of Health Economics, Journal of Antimicrobial Chemotherapy and Rheumatology and has disseminated his work to audiences in Europe and Asia.

He has completed a part-time PhD entitled "Economic analysis alongside multinational studies" at the University of Birmingham.


  • PhD in Health Economics. University of Birmingham 2017
  • MSc Health Economics and Health Policy University of Birmingham 2006
  • BA (Hons) Economics and Geography Kwame Nkrumah University of Science and Technology 2003


Before joining the Health Economics Unit, Raymond Oppong qualified with a BA (Hons) in Economics and Geography (first class) from the Kwame Nkrumah University of Science and Technology Ghana. He went on to work as a teaching assistant at the Department of Economics, KNUST Kumasi, Ghana. 

In 2006, Raymond obtained an MSc in Health Economics and Health Policy from the University of Birmingham. He has since worked as a Research Fellow and Lecturer at the Health Economics Unit. 

Raymond currently works in collaboration with the Arthritis Research UK Primary Care Centre at Keele University on a number of trial based and modelling studies within musculoskeletal disease. 



Raymond’s main research relates to economic evaluations alongside various types of trials such as factorial trials, cluster randomised trials and multinational trials. His most recent research has been related to musculoskeletal disease, where he has been assessing various interventions/programmes for the treatment and management of musculoskeletal disease. Output related to this has been presented at conferences such as the British Society of Rheumatology conference and published in journals such as The Lancet. 

He is also actively involved in research related to the economics of antibiotic resistance and has had the experience of working on the EU funded Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE) project where he took a lead role in designing the health economics aspects of the study. He is currently working on methods for incorporating the cost of antibiotic resistance in economic evaluations. Output from his work on antibiotic resistance has been published in the Journal of Antimicrobial Chemotherapy and British Journal of General Practice and also presented at international conferences such as EuHEA.

Raymond is also interested in methodological work around the economic analysis of different trial designs. For example, his PhD focused on methods for the analysis of multinational trials and he has also been able to develop some methodological work related to the analysis of factorial trials. Output from his work in this area has been published in Rheumatology and PLoS ONE and presented at conferences such as HESG.

Raymond currently coordinates the Research Design Service (RDS) activities in the health economics unit at the University of Birmingham. This team engages in providing advice on the design of economic components of research projects submitted for funding to national competitions. He is actively involved in putting together grant applications and has been a successful co-applicant on a number of grants submitted to the NIHR HTA and NIHR RfPB.


Chesterton L, Blagojevic-Bucknall M, Dziedzic K, Burton C, Davenport G, Jowett S, Myers H, Oppong R, Rathod-Mistry T, van der Windt D, Hay E, Roddy E  (2018) The clinical and cost effectiveness of corticosteroid injection compared with night splints for carpal tunnel syndrome: An open label; parallel group randomised clinical trial (The INSTINCTS trial) Lancet (in press)

 Shrestha P, Cooper B, Coast J, Oppong R, NgaT, Phodha T, Celhay O, Guerin PJ, Wertheim H, Lubell Y (2018) Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use Antibiotic Resistance and Infection Control (in press)

Asamani J, Chebere M, Barton P, D’Almeida S, Odame E, Oppong R (2018) Forecast of Healthcare Facilities and Health Workforce Requirements for the Public Sector in Ghana, 2016 – 2026.  International Journal of Health Policy and Management (in press)

 Oppong R, Smith RD, Little P, Verheij T, Butler CC, Goossens H, Coenen S, Jowett S, Roberts TE, Achana F, Stuart B, Coast J (2018) Cost-effectiveness of internet-based training on antibiotic prescribing for acute respiratory-tract infections in Europe Journal of Antimicrobial Chemotherapy (in press)

 Andronis L, Oppong R,  Senanayake E, Gopal S, Charman S, Giri R, Luckraz H  (2018)Is the Venner-PneuX endotracheal tube system a cost-effective option for post cardiac surgery care? Annals of Thoracic Surgery (In press)

Oppong R, Jowett S, Lewis M, Clarkson K, Paskins Z, Croft P, Edwards JJ, Healey E, Jordan KP, Morden A, Ong Bie Nio, Porcheret M, Finney A, Hay M, Dziedzic K (2018) Cost-effectiveness of a model consultation to support self-management in patients with osteoarthritis Rheumatology 15(6) PP1056-1063

Luckraz H, Manga N, Senanayake E, Abdelaziz M, Gopal S, Charman S, Giri R, Oppong R, Andronis L, (2017) Cost of treating ventilator associated pneumonia post cardiac surgery in the National Health, Service: Results from a propensity-matched cohort study Journal of the Intensive Care Society (in press)

Kamaruzaman H, Kinghorn P, Oppong R (2017)Cost-effectiveness of surgical interventions for the management of osteoarthritis: A systematic review of the literature.  BMC Musculoskeletal Disorders 18:183 DOI 10.1186/s12891-017-1540-2

Oppong R, Smith RD, Little P, Verheij T, Butler CC, Goossens H, Moore M, Coast J (2016) Kosteneffectiviteit van amoxicilline en kost van resistentie Huisarts Nu 45(5), 192

Roddy E, Jordan K, Oppong R, Chen Y, Jowett S, Dawes P, Hider SL, Packham J, Stevenson K, Zwierska I, Hay EM (2016) Re-consultations, self-reported health status, and costs following treatment at a Musculoskeletal Clinical Assessment and Treatment Servive (CATS): a twelve-month prospective cohort study BMJ Open 6:e011735  doi:10.1136/bmjopen-2016-011735

Oppong R, Smith RD, Little P, Verheij T, Butler CC, Goossens H, Coenen S, Moore M, Coast J (2016) Cost-effectiveness of amoxicillin for lower respiratory tract infections in primary care: an economic evaluation accounting for the cost of antimicrobial resistance  British Journal of General Practice DOI: 10.3399/bjgp16X686077

Frempong S, Goranitis I, Oppong R (2015) Economic evaluation alongside factorial trials: A systematic review of empirical studies Expert Review of Pharmacoeconomics and Outcomes Research 15(5)

Oppong R, Jowett S, Roberts T (2015) Economic evaluation alongside multinational studies: A systematic review of empirical studies PLoS ONE 10(6)

Oppong R, Jowett S, Nicholls E, Whitehurst D, Hill S, Hammond A, Hay E, Dziedzic K (2015) Joint protection and hand exercise for hand osteoarthritis: An economic evaluation comparing methods for the analysis of factorial trials Rheumatology 54(5) PP 876-883

Dziedzic K, Healey E, Porcheret M, Ong B, Main C, Jordan K, Lewis M, Edwards J, Jinks C, Morden A, McHugh G, Ryan S, Finney A, Jowett S, Oppong R, Afolabi E et al. (2014) Implementing the NICE osteoarthritis guidelines a mixed methods study and cluster randomised trial of a model osteoarthritis consultation in primary care. The Management of OsteoArthritis In ConsultationS (MOSAICS) study protocol Implementation Science 9:95

Morris K, Oppong R, Holdback N, Coast J (2014) Defining criteria and resource use for high dependency care in children: an observational economic study  Archives of Diseases in Childhood 99(7) PP 652-658

Mistry H, Garnvwa H, Oppong R (2014) Critical appraisal of published systematic reviews assessing the cost-effectiveness of telemedicine studies Telemedicine and e-Health, 20(7) PP 609-618

Mistry H, Oppong R, Frew E. (2014) Health Economics education (HEe) website: A tool to enhance health economics teaching in the United Kingdom.  The Journal of Economic Education, 45(1) 79

Oppong R, Jit M, Smith RD, Butler CC, Melby H, Mölstad S, Coast J (2013) Cost-Effectiveness of Point of Care CRP Testing to Inform Antibiotic Prescribing Decisions British Journal of General Practice 63(612) PP e465- e471

Oppong R, Mistry H, Frew E (2013) Health economics education in undergraduate medical training: Introducing the Health Economics education (HEe) website.  BMC Medical Education, 13 (126)

Oppong R, Kaambwa B, Nuttall J, Hood K, Smith RD, Coast J (2013)The Impact of Using Different Tariffs to Value EQ-5D health state descriptions: An example from a study of acute cough/LRTI in seven countries European Journal of Health Economics 14(2) PP 197-209

Oppong R, Coast J, Hood K, Nuttall J, Smith RD, Butler CC (2011) Resource use and costs of treating lower respiratory tract infections in 13 European countries: Challenges and Results European Journal of Health Economics 12 PP 319-329   

Oppong R, Kaambwa B, Nuttall J, Hood K, Smith RD, Coast J (2011)Assessment of the Construct Validity of EQ-5D in patients with acute cough/LRTI Applied Research in Quality of life 6(4) PP 411-423

View all publications in research portal